Skip to main content
Caplight Logo









Wyndly

Wyndly

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.wyndly.com

Last Round

Series A

Feb 8, 2023

Est. Valuation

$1.79M

Total Funding Raised

$2.13M

Company Overview

Wyndly is a telehealth company that provides personalized, at-home treatment for allergies. The company offers sublingual immunotherapy (allergy drops) intended to provide long-term relief by retraining the body's immune system to ignore allergy triggers. Wyndly combines the convenience of direct-to-consumer telehealth with personalized care from board-certified doctors, shipping allergy tests and treatments directly to patients' doors. Founded in 2020 and a participant in the Y Combinator (W21) batch, the company aims to modernize allergy care and make it more accessible. It has raised $2.12 million in funding from investors including Y Combinator and Goodwater Capital.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Precision Medicine, Subscription Commerce, D2C Brands

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Keywords

allergy dropssublingual immunotherapySLITat-home allergy testtelehealth allergy careallergy shots alternativedirect-to-consumer healthcareD2C healthcaretelemedicinesubscription healthcarepersonalized medicinephysician-led careB2B healthcare services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wyndly Comparables

Compare Wyndly with similar companies based on industry and business-model similarity.

Wyndly comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nectar Life Sciences
93%
Curex
93%
HeyAllergy
89%

Wyndly Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 8, 2023
SeedFeb 12, 2021

Key People

Founding team and executive leadership

Aakash Shah

Chief Executive Officer And Founder

Founding Team

Wyndly Investors

Notable investors and investment history

Wyndly investors
InvestorRounds
Goodwater CapitalSeries A
Y CombinatorSeed, Series A
Sweater VenturesSeries A
Civilization VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2025

    Added Sollis Health FL, Inc. as a customer.

  • Oct 7, 2025

    Added Judge.me Ltd, a SaaS company, as a customer.

Wyndly Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wyndly Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wyndly's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range9
Year Founded2020
Last FundingFeb 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?